Botox vs Dysport vs Xeomin: Brand Comparison

Botulinum toxin type A is the active ingredient behind several well-known brands. Botox, Dysport and Xeomin are the three most widely recognised internationally, and in Korea you will also find many local brands. Patients often ask whether the brand matters, and if so, which one is best.

The honest answer is that all three are effective, established products, and the skill of the injector usually matters more than the brand. There are, however, some real differences in formulation and handling that may influence a doctor's recommendation.

Botox (onabotulinumtoxinA)

Botox, made by Allergan Aesthetics, is the original and most studied brand for cosmetic use. Its toxin is bound to complexing proteins. It has a long track record across many indications, from frown lines to medical uses such as excessive sweating and migraine. Many doctors consider it the reference product against which others are compared.

Dysport (abobotulinumtoxinA)

Dysport, made by Ipsen and marketed for aesthetic use by Galderma in many regions, also contains complexing proteins. Its units are not equivalent to Botox units; a larger number of Dysport units is typically used for a comparable effect, with conversion ratios often quoted around 2.5 to 3 Dysport units per Botox unit, although doctors adjust this in practice.

Some practitioners feel Dysport spreads slightly more from the injection point, which can be useful for larger areas such as the forehead but requires care near the eyes. Some patients report a slightly faster onset.

Xeomin (incobotulinumtoxinA)

Xeomin, made by Merz, is often described as a "naked" toxin because the complexing proteins have been removed during manufacturing. In theory, this may reduce the chance of the body forming neutralising antibodies, which can make toxin less effective over time. Xeomin units are generally considered roughly equivalent to Botox units. It can also be stored at room temperature before reconstitution, which is a practical advantage for clinics.

Side-by-side comparison

• Complexing proteins: Botox and Dysport contain them; Xeomin does not.
• Unit equivalence: Botox and Xeomin are approximately one to one; Dysport uses more units for a similar effect.
• Spread: Dysport is often described as spreading slightly more; Botox and Xeomin are considered more localised, although technique and dilution matter greatly.
• Onset: all typically begin within a few days and peak at around two weeks; some patients feel Dysport works slightly faster.
• Duration: all usually last around three to four months for expression lines, with individual variation.
• Resistance: Xeomin is sometimes preferred for patients concerned about antibody formation, although resistance is uncommon with any brand at cosmetic doses.

Where Korean toxins fit in

Korea has a large domestic toxin industry. Brands such as Botulax, Nabota, Meditoxin and Hutox are widely used in Korean clinics and are often more affordable than imported brands. Nabota is also sold in some other markets under the name Jeuveau. Many Korean doctors use these products routinely and are very familiar with their dosing.

Some clinics also offer toxins with reduced complexing proteins, marketed as having a lower risk of resistance. If you have had repeated treatments and notice weaker results over time, it is worth discussing this with your doctor.

Does the brand really matter?

For most people having occasional cosmetic treatment, any reputable brand in experienced hands will give good results. Brand may matter more in a few situations:

• You have had a strong or poor response to a particular brand before.
• You have frequent, high-dose treatments, such as masseter and shoulder toxin together, and want to minimise resistance risk.
• You want to continue with the same brand you use at home for consistency.
• You have a preference for a specific product for personal or budget reasons.

Safety and who should avoid toxin

All botulinum toxin brands share similar side effects, including bruising, headache, and occasionally a heavy brow, drooping eyelid or asymmetric expression, which is usually temporary. Serious side effects are rare at cosmetic doses.

• Pregnant or breastfeeding patients should avoid treatment.
• People with neuromuscular disorders should not be treated without specialist advice.
• Those with an allergy to any component of a product should avoid that brand.
• Anyone with infection at the injection site should postpone.

Which should you choose?

• First-time patient wanting a well-established option: Botox or a reputable Korean brand are common choices.
• Concerned about resistance after many treatments: Xeomin or a low-protein toxin may be suggested.
• Large forehead area: some doctors prefer Dysport for its spread, others use any brand with adjusted technique.
• Budget-conscious: Korean brands are often a sensible option.

In Korea, it is reasonable to ask which brand will be used before treatment and, if possible, to see the vial. Confirm the number of units planned, since unit comparisons between brands are not one to one, and note the brand and dose so your doctor at home can continue consistently. Avoid lying down, heavy exercise, saunas and facial massage for several hours to a day after treatment, and allow two weeks to judge the result. Because toxin treatment generally has little downtime, it can be scheduled later in your stay.

Conclusion

Botox, Dysport and Xeomin are all effective botulinum toxin products with subtle differences in formulation, spread and unit dosing. Korean brands offer further well-established options. For most people, the experience and judgement of the injector matter more than the label on the vial. Discuss your history, preferences and goals with a doctor, who can recommend the most suitable brand and dose.

This article is for general information only and is not a substitute for a medical consultation. Suitability, results and recovery vary from person to person.